Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
Open accessThe DOI matches its Crossref record; 144 of the 146 references it cites were found in a registry or an index.
Abstract
Candidemia, the commonest invasive fungal infection, is associated with high morbidity and mortality in developing countries, though the exact prevalence is not known due to lack of systematic epidemiological data from those countries. The limited studies report a very high incidence of candidemia and unique epidemiology with a different spectrum of Candida species. The recent global emergence of multi-drug resistant Candida auris is looming large as an important threat in hospitalized patients of developing countries. While managing candidemia cases in those countries several challenges are faced, which include poor infrastructure; compromised healthcare and infection control practices; misuse and overuse of antibiotics and steroids; lack of awareness in fungal infections; non-availability of advance diagnostic tests and antifungal drugs in many areas; poor compliance to antifungal therapy and stewardship program. Considering the above limitations, innovative strategies are required to reduce mortality due to candidemia in adults and neonates. In the present review, we have unraveled the challenges of candidemia faced by low resource countries and propose a ten part strategy to reduce mortality due candidemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The incidence of candidaemia was higher in middle income countries and this can be linked to compromised healthcare systems, deficiency in resources, poor infection control implementation, unavailability of diagnostic tests allowing excess empirical therapy, impaired knowledge about fungal infections or misuse of antibiotics without stewardship programs [47].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 9×
“Population-based accurate data is also scarce from developed nations, as the majority of these studies are hospital-based or target specific patient groups, with the exceptions being France, Australia and Iceland [8].”
BackgroundInfluentialInternational Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 10×
“Candida mannan and anti-mannan antibody detection have gained greater acceptance in Europe than the United States [80,81].”
BackgroundInfluentialEffectiveness of a hospital-wide programme to improve compliance with hand hygiene
Pittet, D., Hugonnet, S., Harbarth, S., Mourouga, P., Sauvan, V., Touveneau, S., & Perneger, T. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02814-2 · Cited by 2,524
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Kullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286 · cited 1×
“5–2 times patients survive) in adults in ICU [110,111,126].”
BackgroundGarey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171 · cited 1×
“5–2 times patients survive) in adults in ICU [110,111,126].”
BackgroundAttributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Role of hand hygiene in healthcare-associated infection prevention
Allegranzi, B., & Pittet, D. (2009) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.04.019 · Cited by 1,044 · cited 1×
“Adequate maintenance of hand hygiene reduces rates of nosocomial infections and cross-transmission as shown in many studies over the last few decades [106].”
BackgroundDoron, S., & Snydman, D. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ085 · Cited by 942
Anidulafungin versus Fluconazole for Invasive Candidiasis
Reboli, A. C., Rotstein, C., Pappas, P. G., Chapman, S. W., Kett, D. H., Kumar, D., Betts, R., Wible, M., Goldstein, B. P., Schranz, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066906 · Cited by 894
Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793
Evidence-based model for hand transmission during patient care and the role of improved practices
Pittet, D., Allegranzi, B., Sax, H., Dharan, S., Pessoa-Silva, C. L., Donaldson, L., & Boyce, J. M. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70600-4 · Cited by 790 · cited 1×
“to patient and environment to patient [105].”
Kuse, E.-R., Chetchotisakd, P., da Cunha, C. A., Ruhnke, M., Barrios, C., Raghunadharao, D., Sekhon, J. S., Freire, A., Ramasubramanian, V., Demeyer, I., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60605-9 · Cited by 692
Clancy, C. J., & Nguyen, M. H. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit006 · Cited by 688 · cited 1×
“Approximately 50% of candidemia cases may yield negative blood culture results [73].”
BackgroundParczewska, O. K., Posaconazol, przeciwgrzybicze, L., Anidulafungina, Micafungina, & wrażliwość, O. (2009) · Cited by 656
Epidemiology and risk factors for invasive candidiasis
Yapar, N. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s40160 · Cited by 610 · cited 2×
“Country-wise distribution of Candida species causing candidemia [9,26].”
BackgroundChanging epidemiology of systemic fungal infections
Richardson, M., & Lass-Flörl, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01978.x · Cited by 524 · cited 1×
“albicans isolation is much lower in developing countries, and in some Asian countries the rate has gone down to <10% [46].”
BackgroundSeptic shock attributed to Candida infection: Importance of empiric therapy and source control.
Kollef, M., Micek, S., Hampton, N., Doherty, J. A., & Kumar, A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis305 · Cited by 477 · cited 2×
“Due to the limitation of laboratory diagnostics, various clinical prediction rules are proposed to identify the patients likely to have IC [88].”
BackgroundIncidence, characteristics and outcome of ICU-acquired candidemia in India
Chakrabarti, A., Sood, P., Rudramurthy, S. M., Chen, S., Kaur, H., Capoor, M., Chhina, D., Rao, R., Eshwara, V. K., Xess, I., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-014-3603-2 · Cited by 454 · cited 16×
“However, in developing countries the Candida colonization may occur much earlier, as in an Indian study >70% of the pre-term neonates were colonized within a week and 38% colonized within 24 h of delivery.”
BackgroundMethodResultInfluentialSelf-citationT2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
Mylonakis, E., Clancy, C. J., Ostrosky-Zeichner, L., Garey, K. W., Alangaden, G. J., Vazquez, J. A., Groeger, J. S., Judson, M. A., Vinagre, Y.-M., Heard, S. O., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu959 · Cited by 443
Pfaller, M., Neofytos, D., Diekema, D., Azie, N., Meier-Kriesche, H.-U., Quan, S.-P., & Horn, D. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.10.003 · Cited by 394 · cited 1×
“Local epidemiology: A wide range of variation is observed in Candida species distribution between developing countries, even within the countries [95,115,116].”
BackgroundInfection control as a major World Health Organization priority for developing countries
Pittet, D., Allegranzi, B., Storr, J., Nejad, S. B., Dziekan, G., Leotsakos, A., & Donaldson, L. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2007.12.013 · Cited by 380 · cited 1×
“Even the limited availability of clean water and soap at hand-washing sites pose hurdles to maintain hand hygiene compliance [6].”
BackgroundEpidemiology of invasive candidiasis
Arendrup, M. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e84d2 · Cited by 376 · cited 1×
“The comorbidities for a higher risk of candidemia include acute necrotizing pancreatitis, haematological malignancies, solid organ tumours, neutropenia (<500/mm3), deteriorating clinical condition, chronic renal insufficiency and previous candidemia attacks [52,53].”
BackgroundNeonatal Candidiasis: Epidemiology, Risk Factors, and Clinical Judgment
Benjamin, D. K., Stoll, B. J., Gantz, M. G., Walsh, M. C., Sánchez, P. J., Das, A., Shankaran, S., Higgins, R. D., Auten, K. J., Miller, N. A., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-3412 · Cited by 375 · cited 1×
“The attributable mortality rate was recorded at 12–20% [66,67].”
BackgroundHand hygiene: Back to the basics of infection control
Mathur, P. (2011) · Indian Journal of Medical Research · doi:10.4103/0971-5916.90985 · Cited by 372
Candida auris candidaemia in Indian ICUs: analysis of risk factors
Rudramurthy, S. M., Chakrabarti, A., Paul, R. A., Sood, P., Kaur, H., Capoor, M. R., Kindo, A. J., Marak, R. S. K., Arora, A., Sardana, R., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx034 · Cited by 357 · cited 11×
“However, in developing countries the Candida colonization may occur much earlier, as in an Indian study >70% of the pre-term neonates were colonized within a week and 38% colonized within 24 h of delivery.”
BackgroundInfluentialSelf-citationA Multicenter, Randomized Trial of Prophylactic Fluconazole in Preterm Neonates
Manzoni, P., Stolfi, I., Pugni, L., Decembrino, L., Magnani, C., Vetrano, G., Tridapalli, E., Corona, G., Giovannozzi, C., Farina, D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065733 · Cited by 356 · cited 1×
“Even nystatin prophylaxis decreases mortality by 50–60% [121,122].”
BackgroundMolecular and Nonmolecular Diagnostic Methods for Invasive Fungal Infections
Arvanitis, M., Anagnostou, T., Fuchs, B. B., Caliendo, A. M., & Mylonakis, E. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00091-13 · Cited by 353 · cited 1×
“Bactec 9240 and Bac/T Alert take around 14–72 h for beeping positive signal based on the culture condition and burden of yeast cells [71,72].”
BackgroundThe changing epidemiology of healthcare-associated candidemia over three decades
Diekema, D., Arbefeville, S., Boyken, L., Kroeger, J., & Pfaller, M. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.02.001 · Cited by 309 · cited 1×
“Local epidemiology: A wide range of variation is observed in Candida species distribution between developing countries, even within the countries [95,115,116].”
BackgroundNeonatal sepsis: Progress towards improved outcomes
Shane, A. L., & Stoll, B. J. (2014) · Journal of Infection · doi:10.1016/j.jinf.2013.09.011 · Cited by 297
Pfaller, M. A., Moet, G. J., Messer, S. A., Jones, R. N., & Castanheira, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01398-10 · Cited by 228
Pappas, P. G. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.07.004 · Cited by 227
Chow, J. K., Golan, Y., Ruthazer, R., Karchmer, A. W., Carmeli, Y., Lichtenberg, D., Chawla, V., Young, J., & Hadley, S. (2008) · Clinical Infectious Diseases · doi:10.1086/529435 · Cited by 223
Cassone, M., Serra, P., Mondello, F., Girolamo, A., Scafetti, S., Pistella, E., & Venditti, M. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5340-5343.2003 · Cited by 215
Doi, A. M., Pignatari, A. C. C., Edmond, M. B., Marra, A. R., Camargo, L. F. A., Siqueira, R. A., da Mota, V. P., & Colombo, A. L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146909 · Cited by 215
Betts, R. F., Nucci, M., Talwar, D., Gareca, M., Queiroz‐Telles, F., Bedimo, R. J., Herbrecht, R., Ruiz‐Palacios, G., Young, J. H., Baddley, J. W., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598933 · Cited by 214
Zaoutis, T. E., Prasad, P. A., Localio, A. R., Coffin, S. E., Bell, L. M., Walsh, T. J., & Gross, R. (2010) · Clinical Infectious Diseases · doi:10.1086/655698 · Cited by 208
Epidemiology of candidemia in intensive care units
Bouza, E., & Muñoz, P. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70006-2 · Cited by 207
Point-Counterpoint: β- d -Glucan Testing Is Important for Diagnosis of Invasive Fungal Infections
Theel, E. S., & Doern, C. D. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01737-13 · Cited by 203 · cited 1×
“The detection of (1,3)-β-D-glucan (BDG), a component of fungal cell wall (except Mucorales, Cryptococcus) is a promising fungal biomarker for early diagnosis of invasive infection and initiation of pre-emptive antifungal therapy [57,79].”
BackgroundDimopoulos, G., Ntziora, F., Rachiotis, G., Armaganidis, A., & Falagas, M. E. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181607262 · Cited by 189 · cited 1×
“It is observed that the candidemia caused by NAC species has an independent association with the use of central venous catheter, glucocorticoids and presence of candiduria [58].”
BackgroundBaley, J. E., Meyers, C., Kliegman, R. M., Jacobs, M. R., & Blumer, J. L. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82674-5 · Cited by 184 · cited 1×
“The volume and clearance of liposomal amphotericin B varies with weight in neonates and children [97].”
BackgroundAndes, D. R., Safdar, N., Baddley, J. W., Alexander, B., Brumble, L., Freifeld, A., Hadley, S., Herwaldt, L., Kauffman, C., Lyon, G. M., et al. (2016) · Transplant Infectious Disease · doi:10.1111/tid.12613 · Cited by 182
Pfaller, M. A., Castanheira, M., Messer, S. A., Moet, G. J., & Jones, R. N. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.06.015 · Cited by 180 · cited 1×
“Local epidemiology: A wide range of variation is observed in Candida species distribution between developing countries, even within the countries [95,115,116].”
BackgroundLoyse, A., Thangaraj, H., Easterbrook, P., Ford, N., Roy, M., Chiller, T., Govender, N., Harrison, T. S., & Bicanic, T. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70078-1 · Cited by 177 · cited 2×
“Availability of antifungal drugs: A big barrier is faced by low-income and middle-income countries to access antifungal agents, and the drug cost [117].”
BackgroundPopulation Pharmacokinetics of Fluconazole in Young Infants
Wade, K. C., Wu, D., Kaufman, D. A., Ward, R. M., Benjamin, D. K., Sullivan, J. E., Ramey, N., Jayaraman, B., Hoppu, K., Adamson, P. C., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00569-08 · Cited by 177
Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study
Tan, B. H., Chakrabarti, A., Li, R. Y., Patel, A. K., Watcharananan, S. P., Liu, Z., Chindamporn, A., Tan, A. L., Sun, P.-L., Wu, U.-I., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.06.010 · Cited by 176 · cited 2×
“7–59% [17] Italy 35% [31,36] Kuwait 15–60% [42] Australia 21% (SOT) [43] Brazil 50–72.”
Self-citationGlobal access to antifungal therapy and its variable cost
Kneale, M., Bartholomew, J. S., Davies, E., & Denning, D. W. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw325 · Cited by 175 · cited 3×
“The available data shows a listing of amphotericin B on the EML in 11 countries only [129].”
BackgroundInfluentialMesser, S. A., Jones, R. N., & Fritsche, T. R. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1782-1787.2006 · Cited by 172
Steinbach, W. J., Roilides, E., Berman, D., Hoffman, J. A., Groll, A. H., Bin-Hussain, I., Palazzi, D. L., Castagnola, E., Halasa, N., Velegraki, A., et al. (2012) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182737427 · Cited by 171
Riquelme, A. J., Calvo, M. A., Guzmán, A. M., Depix, M. S., García, P., Pérez, C., Arrese, M., & Labarca, J. A. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200301000-00013 · Cited by 166
Changing epidemiology of candidaemia in Australia
Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., Bak, N., Heath, C. H., Kennedy, K., Morrissey, C. O., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw422 · Cited by 163 · cited 1×
“reported implementation of aggressive hand hygiene practices in addition to fluconazole prophylaxis to be more successful in preventing candidemia in preterm infants of <33 weeks in NICU than prophylaxis alone [13].”
BackgroundNosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis
Pfaller, M. A., & Castanheira, M. (2015) · Medical Mycology · doi:10.1093/mmy/myv076 · Cited by 161 · cited 3×
“The aim of this program is to achieve the best outcome without unnecessary adverse reactions and emergence of drug resistance [54].”
BackgroundWenzel, R. P., & Gennings, C. (2005) · Clinical Infectious Diseases · doi:10.1086/430923 · Cited by 159
T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis
Pfaller, M. A., Wolk, D. M., & Lowery, T. J. (2016) · Future Microbiology · doi:10.2217/fmb.15.111 · Cited by 157 · cited 2×
“Early diagnosis of candidemia is associated with reduced morbidity and mortality, hospital stay, cost and drug toxicity [70].”
BackgroundHealy, C. M., Campbell, J. R., Zaccaria, E., & Baker, C. J. (2008) · Pediatrics · doi:10.1542/peds.2007-1130 · Cited by 153
Stoll, B., & Shane, A. (2013) · American Journal of Perinatology · doi:10.1055/s-0032-1333413 · Cited by 150 · cited 8×
“Early enteral feeding also promotes the development of healthy gut microflora [34].”
BackgroundInfluentialChanging epidemiology of candidaemia in Australia
Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., Bak, N., Heath, C. H., Kennedy, K., Morrissey, C. O., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx047 · Cited by 149
Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*
Puig-Asensio, M., Pemán, J., Zaragoza, R., Garnacho-Montero, J., Martín-Mazuelos, E., Cuenca-Estrella, M., & Almirante, B. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000221 · Cited by 147 · cited 3×
“7–59% [17] Italy 35% [31,36] Kuwait 15–60% [42] Australia 21% (SOT) [43] Brazil 50–72.”
BackgroundGhosh, A. K., Paul, S., Sood, P., Rudramurthy, S. M., Rajbanshi, A., Jillwin, T. J., & Chakrabarti, A. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.11.009 · Cited by 142 · cited 1×
“MALDI-TOF MS has immensely revolutionized the identification of Candida species by decreasing the turnaround time to <3 h as compared to 2–7 days by conventional as well as sequence-based techniques [76].”
MethodSelf-citationBenjamin, D. K., DeLong, E. R., Cotten, C. M., Garges, H. P., Steinbach, W. J., & Clark, R. H. (2004) · Journal of Perinatology · doi:10.1038/sj.jp.7211068 · Cited by 138
Bassetti, M., Trecarichi, E. M., Righi, E., Sanguinetti, M., Bisio, F., Posteraro, B., Soro, O., Cauda, R., Viscoli, C., & Tumbarello, M. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.01.005 · Cited by 135 · cited 1×
“The comorbidities for a higher risk of candidemia include acute necrotizing pancreatitis, haematological malignancies, solid organ tumours, neutropenia (<500/mm3), deteriorating clinical condition, chronic renal insufficiency and previous candidemia attacks [52,53].”
Background(1,3)- -D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis
Jaijakul, S., Vazquez, J. A., Swanson, R. N., & Ostrosky-Zeichner, L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis456 · Cited by 134 · cited 1×
“They noticed a negative slope in BDG levels of successfully managed patients (PPV 90%) while a positive slope was found in patients with treatment failure (NPV 90%) [82].”
BackgroundPopulation Pharmacokinetics of Micafungin in Neonates and Young Infants
Hope, W. W., Smith, P. B., Arrieta, A., Buell, D. N., Roy, M., Kaibara, A., Walsh, T. J., Cohen-Wolkowiez, M., & Benjamin, D. K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01679-09 · Cited by 129 · cited 1×
“Caspofungin and micafungin are approved by the FDA for use in children whose dosing is based on body surface area rather than weight [101].”
BackgroundPharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life
Saxén, H., Hoppu, K., & Pohjavuori, M. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.147 · Cited by 127
Healy, C. M., Baker, C. J., Zaccaria, E., & Campbell, J. R. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.04.016 · Cited by 127
Cruciani, M., de Lalla, F., & Mengoli, C. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2794-y · Cited by 127
Safety and pharmacokinetics of fluconazole in children with neoplastic diseases
Lee, J. W., Seibel, N. L., Amantea, M., Whitcomb, P., Pizzo, P. A., & Walsh, T. J. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81975-4 · Cited by 120
León, C., Ostrosky-Zeichner, L. L., & Schuster, M. G. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3281-0 · Cited by 118 · cited 1×
“The test has a sensitivity of 77–89% and a specificity of 91–100% [83].”
BackgroundGrim, S. A., Berger, K., Teng, C., Gupta, S., Layden, J. E., Janda, W. M., & Clark, N. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr511 · Cited by 118 · cited 1×
“It had been shown that high mortality still occurs even when the antifungal is initiated in a timely manner [112].”
BackgroundThe Candidemia Study Group, Barchiesi, F., Orsetti, E., Gesuita, R., Skrami, E., & Manso, E. (2015) · Infection · doi:10.1007/s15010-015-0845-z · Cited by 113 · cited 1×
“It is estimated that the incidence of candidemia has increased five-fold globally in the last 10 years [3].”
BackgroundRisk Factors of Catheter‐Related Bloodstream Infections in Parenteral Nutrition Catheterization
Yılmaz, G., Köksal, İ., Aydın, K., Çaylan, R., Sucu, N., & Aksoy, F. (2007) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607107031004284 · Cited by 112 · cited 1×
“Hand hygiene also reduced CLABSI rate by 72% in patients receiving parenteral nutrition [108].”
BackgroundHong, Y., Shaw, P. J., Nath, C. E., Yadav, S. P., Stephen, K. R., Earl, J. W., & McLachlan, A. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.935-942.2006 · Cited by 102 · cited 1×
“The safety, efficacy, area under the curve, and maximal concentration (2–5 μg/mL) of amphotericin B lipid complex (ABLC) are similar in adults and children [96].”
BackgroundZaoutis, T. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.487796 · Cited by 102
Asmundsdottir, L. R., Erlendsdottir, H., & Gottfredsson, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02566-12 · Cited by 100
Antifungal stewardship in invasive Candida infections
Ruhnke, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12622 · Cited by 99 · cited 2×
“Antifungal stewardship: The rational use of antifungal agents in health care institutions must be followed for monitoring and guiding the appropriate antifungal use including dosing, duration of therapy, and route of administration [130].”
BackgroundEarly treatment of candidemia in adults: a review
Ostrosky-Zeichner, L., Kullberg, B. J., Bow, E. J., Hadley, S., León, C., Nucci, M., Patterson, T. F., & Perfect, J. R. (2011) · Medical Mycology · doi:10.3109/13693786.2010.512300 · Cited by 97 · cited 5×
“This recommendation has been found to be useful to start pre-emptive therapy in surgical ICUs rather than medical ICUs in developed countries [57].”
BackgroundMethodInfluentialOlowe, O., Makanjuola, O., Olowe, R., & Adekanle, D. (2014) · European Journal of Microbiology and Immunology · doi:10.1556/eujmi-d-14-00027 · Cited by 95
Reboli, A. C., Shorr, A. F., Rotstein, C., Pappas, P. G., Kett, D. H., Schlamm, H. T., Reisman, A. L., Biswas, P., & Walsh, T. J. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-261 · Cited by 94
Challenging the world: patient safety and health care-associated infection
Pittet, D., & Donaldson, L. (2006) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzi093 · Cited by 93
Emergence of non-albicans candida species in neonatal candidemia
Juyal, D., Sharma, M., Pal, S., Rathaur, V., & Sharma, N. (2013) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.118919 · Cited by 84 · cited 6×
“C. parapsilosis is considered the most common NAC species isolated from babies in NICUs [37].”
BackgroundInfluentialBeyda, N. D., Alam, M. J., & Garey, K. W. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.07.007 · Cited by 84 · cited 1×
“Recently, T2 Candida panel has been developed and approved by United States Food and drug Administration (FDA), allowing rapid diagnosis and identification of Candida species directly from blood [74].”
BackgroundProcalcitonin levels in surgical patients at risk of candidemia
Martini, A., Gottin, L., Menestrina, N., Schweiger, V., Simion, D., & Vincent, J. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.03.003 · Cited by 82 · cited 2×
“Few studies have evaluated the role of a known bacterial sepsis marker, procalcitonin (PCT), in diagnosing candidemia [85].”
BackgroundDing, X., Yan, D., Sun, W., Zeng, Z., Su, R., & Su, J. (2015) · Medical Mycology · doi:10.1093/mmy/myv060 · Cited by 81
Epidemiology and reporting of candidaemia in Belgium: a multi-centre study
Trouvé, C., Blot, S. I., Hayette, M., Jonckheere, S., Patteet, S., Rodriguez‐Villalobos, H., Symoens, F., Wijngaerden, E. V., & Lagrou, K. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2841-3 · Cited by 81
Tadec, L., Talarmin, J., Gastinne, T., Bretonnière, C., Miegeville, M., Le Pape, P., & Morio, F. (2016) · Mycoses · doi:10.1111/myc.12470 · Cited by 80
Trends in Candida Central Line-Associated Bloodstream Infections Among NICUs, 1999–2009
Chitnis, A. S., Magill, S. S., Edwards, J. R., Chiller, T. M., Fridkin, S. K., & Lessa, F. C. (2012) · Pediatrics · doi:10.1542/peds.2011-3620 · Cited by 78 · cited 1×
“to improved central line insertion and maintenance practices over a period of 10 years [141].”
BackgroundCharles, P. E., Kus, E., AHO, S., Prin, S., Doise, J.-M., Olsson, N.-O., Blettery, B., & Quenot, J.-P. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-49 · Cited by 76
Hirano, R., Sakamoto, Y., Kudo, K., & Ohnishi, M. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s80677 · Cited by 74
Preventing invasive candida infections. Where could we do better?
Eggimann, P., Que, Y.-A., Revelly, J.-P., & Pagani, J.-L. (2015) · Journal of Hospital Infection · doi:10.1016/j.jhin.2014.11.006 · Cited by 74
Rodriguez, L., Bustamante, B., Huaroto, L., Agurto, C., Illescas, R., Ramirez, R., Diaz, A., & Hidalgo, J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175172 · Cited by 72
Yang, Z.-T., Wu, L., Liu, X.-Y., Zhou, M., Li, J., Wu, J.-Y., Cai, Y., Mao, E.-Q., Chen, E.-Z., & Lortholary, O. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-241 · Cited by 71
Antifungal Prophylaxis to Prevent Neonatal Candidiasis: A Survey of Perinatal Physician Practices
Burwell, L. A., Kaufman, D., Blakely, J., Stoll, B. J., & Fridkin, S. K. (2006) · Pediatrics · doi:10.1542/peds.2006-0446 · Cited by 69 · cited 1×
“The majority of cases of invasive fungal infections in neonatal intensive care units (NICUs) are due to Candida species (third most common cause of late onset sepsis in <1500 g) [59,60].”
BackgroundEvaluation of species distribution and risk factors of candidemia: A multicenter case-control study
Yapar, N., Pullukcu, H., Avkan-Oguz, V., Sayin-Kutlu, S., Ertugrul, B., Sacar, S., Cetin, B., & Kaya, O. (2011) · Medical Mycology · doi:10.3109/13693786.2010.501344 · Cited by 69
Apisarnthanarak, A., Yatrasert, A., & Mundy, L. M. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/653616 · Cited by 69
Trends in neonatal septicemia: emergence of non-albicans Candida.
Agarwal, J., Bansal, S., Malik, G. K., & Jain, A. (2004) · PubMed · Cited by 68
Challenging issues in neonatal candidiasis
Kaufman, D. A. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.487799 · Cited by 66 · cited 1×
“babies have multiple co-morbidities and face the challenges of prematurity, infections, haemorrhage, necrotizing enterocolitis (NEC), respiratory distress syndrome or congenital anomalies like patent ductus arteriosus [34,61,63].”
BackgroundSeven cases of Saccharomyces fungaemia related to use of probiotics
Roy, U., Jessani, L. G., Rudramurthy, S. M., Gopalakrishnan, R., Dutta, S., Chakravarty, C., Jillwin, J., & Chakrabarti, A. (2017) · Mycoses · doi:10.1111/myc.12604 · Cited by 66 · cited 1×
“Clinical trials conducted in preterm neonates demonstrated a favorable effect of Saccharomyces boulardii containing probiotics without any evidence of fungemia or sepsis [136].”
BackgroundSelf-citationvan Hal, S. J., Marriott, D. J. E., Chen, S. C.-A., Nguyen, Q. A., Sorrell, T. C., Ellis, D. H., Slavin, M. A., & Study, T. A. C. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2009.00371.x · Cited by 65 · cited 2×
“South Africa 60% [23] n, neonates; i, infants; p, paediatrics; elbw, extremely low birth weight; ICU, intensive care unit; SOT, solid organ transplant.”
Parikh, T. B., Nanavati, R. N., Patankar, C. V., Rao, S. P., Bisure, K., Udani, R. H., & Mehta, P. R. (2007) · PubMed · Cited by 64
Persistent candidemia in neonatal care units: risk factors and clinical significance
Hammoud, M. S., Al-Taiar, A., Fouad, M., Raina, A., & Khan, Z. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.11.020 · Cited by 63
Next-Generation Sequencing in the Mycology Lab
Zoll, J., Snelders, E., Verweij, P. E., & Melchers, W. J. G. (2016) · Current Fungal Infection Reports · doi:10.1007/s12281-016-0253-6 · Cited by 53
Wang, H., Liu, N., Yin, M., Han, H., Yue, J., Zhang, F., Shan, T., Guo, H., & Wu, D. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0609-x · Cited by 52
Ariff, S., Saleem, A. F., Soofi, S. B., & Sajjad, R. (2011) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.1232 · Cited by 52 · cited 2×
“5% of sick neonates within the first two weeks of life [41].”
BackgroundAtıcı, S., Soysal, A., Karadeniz Cerit, K., Yılmaz, Ş., Aksu, B., Kıyan, G., & Bakır, M. (2017) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2017.02.002 · Cited by 52 · cited 1×
“It is therefore recommended to use probiotics cautiously in pre-term neonates and immunocompromised patients [139].”
BackgroundYu, Y., Yuan, T., Zheng, J.-Y., Chen, A., Chen, L., Shi, L., & Du, L. (2012) · American Journal of Perinatology · doi:10.1055/s-0032-1329688 · Cited by 51
Fungal infections in the ICU: advances in treatment and diagnosis
PASCALE, G. D., & Tumbarello, M. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000230 · Cited by 47 · cited 1×
“The results are encouraging due to rapidity and sensitivity of diagnosis compared to blood culture [84].”
BackgroundLagunes, L., Rey-Perez, A., Martín-Gómez, M. T., Vena, A., de Egea, V., Muñóz, P., Bouza, E., Díaz‐Martín, A., Palacios-García, I., Garnacho‐Montero, J., et al. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2775-9 · Cited by 47 · cited 2×
“(Spain) conducted a retrospective, multi-center, cohort study in surgical wards and ICUs and reported adequate source control in 60% of patients with intra-abdominal candidiasis (IAC) within 48 h of diagnosis [109].”
BackgroundEpidemiology and cost implications of candidemia, a 6‐year analysis from a developing country
Ulu Kilic, A., Alp, E., Cevahir, F., Ture, Z., & Yozgat, N. (2017) · Mycoses · doi:10.1111/myc.12582 · Cited by 47
López-Cortés, L. E., Almirante, B., Cuenca‐Estrella, M., Garnacho‐Montero, J., Padilla, B., Puig‐Asensio, M., Ruíz-Camps, I., Rodríguez‐Baño, J., Padilla, B., Muñóz, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.05.008 · Cited by 44
Goel, N., Ranjan, P. K., Aggarwal, R., Chaudhary, U., & Nanda, S. (2009) · Journal of Laboratory Physicians · doi:10.4103/0974-2727.59699 · Cited by 43
Ellis, M., Hedstrom, U., Jumaa, P., & Bener, A. (2003) · Medical Mycology · doi:10.1080/13693780310001645337 · Cited by 42
Candidemia among adults in Soweto, South Africa, 1990–2007
Kreusch, A., & Karstaedt, A. S. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.02.010 · Cited by 42
Recommendations for the management of candidemia in adults in Latin America
Nucci, M., Thompson-Moya, L., Guzman-Blanco, M., Tiraboschi, I. N., Cortes, J. A., Echevarría, J., Sifuentes, J., Zurita, J., Santolaya, M. E., Alvarado Matute, T., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.007 · Cited by 41
Lowbury Lecture 2008: infection control and limited resources – searching for the best solutions
Raka, L. (2009) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.03.017 · Cited by 40
Kaufman, D. A. (2012) · Early Human Development · doi:10.1016/s0378-3782(12)70014-2 · Cited by 39
Yeast colonisation & fungaemia in preterm neonates in a tertiary care centre.
Singh, K., Chakrabarti, A., Narang, A., & Gopalan, S. (1999) · PubMed · Cited by 39
Self-citationRisk factors and clinical analysis of candidemia in very-low-birth-weight neonates
Fu, J., Wang, X., Wei, B., Jiang, Y., & Chen, J. (2016) · American Journal of Infection Control · doi:10.1016/j.ajic.2016.03.026 · Cited by 39 · cited 1×
“Further, studies have identified carbapenem use, total parenteral nutrition, central venous lines use, intubation, congenital malformations, low APGAR score and increased hospital stay as risk factors for neonatal candidemia [64,65].”
BackgroundRecommendations for the management of candidemia in children in Latin America
Santolaya, M. E., Telles, F. D. Q., Matute, T. A., Colombo, A. L., Zurita, J., Tiraboschi, I. N., Cortés, J. A., Thompson-Moya, L., Guzmán-Blanco, M., Sifuentes‐Osornio, J., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.010 · Cited by 38 · cited 1×
“Few experts in Latin America have made recommendations for the treatment of candidemia in adults, children and neonates based on current clinical evidence, the regional epidemiology, and expert opinions [50,102,104].”
BackgroundEmerging drugs and vaccines for Candidemia
Moriyama, B., Gordon, L. A., McCarthy, M., Henning, S. A., Walsh, T. J., & Penzak, S. R. (2014) · Mycoses · doi:10.1111/myc.12265 · Cited by 37 · cited 2×
“Currently, two vaccine candidates in clinical trials, namely NDV-3 and rHyr1p-N, are prophylactic recombinant vaccines with an Alhydrogel® adjuvant against the N-terminal region of the agglutinin-like sequence 3 protein (Als3p) and Hyr1p, respectively [142].”
BackgroundFu, Y., Chen, J., Cai, B., Zhang, J., Li, L., Liu, C., Kang, Y., & Wang, L. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.12.019 · Cited by 36 · cited 2×
“5 pg/mL) has been shown to increase the sensitivity or specificity for diagnosing Candida sepsis [87].”
BackgroundKludze-Forson, M., Eschenauer, G. A., Kubin, C. J., Della‐Latta, P., & Lam, S. W. (2009) · Medical Mycology · doi:10.3109/13693780903208256 · Cited by 33 · cited 1×
“On the contrary, few studies did not find any role of early antifungal therapy in decreasing mortality [127].”
ResultStudy of clinical spectrum and risk factors of neonatal candidemia
Wadile, R. G., & Bhate, V. (2015) · Indian Journal of Pathology and Microbiology · doi:10.4103/0377-4929.168888 · Cited by 31 · cited 2×
“Modern medicine and surgical techniques have enhanced life expectancy of premature and low birth weight (LBW) babies, but have increased the risk of candidemia [34,60,61].”
BackgroundRecommendations for the management of candidemia in neonates in Latin America
Santolaya, M. E., Matute, T. A., Telles, F. D. Q., Colombo, A. L., Zurita, J., Tiraboschi, I. N., Cortés, J. A., Thompson-Moya, L., Guzmán-Blanco, M., Sifuentes‐Osornio, J., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.012 · Cited by 30
Yeast Infection and Diabetes Mellitus among Pregnant Mother in Malaysia.
Sopian, I. L., Shahabudin, S., Ahmed, M. A., Than, L. T. L., & Sandai, D. A. (2016) · Europe PMC (PubMed Central) · Cited by 29
Zhang, L., Wang, H., Xiao, M., Kudinha, T., Mao, L.-L., Zhao, H.-R., Kong, F., & Xu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114004 · Cited by 28
Recomendaciones para el manejo de la candidemia en niños en América Latina
Santolaya, M. E., Telles, F. D. Q., Matute, T. A., Colombo, A. L., Zurita, J., Tiraboschi, I. N., Cortés, J. A., Thompson-Moya, L., Guzmán-Blanco, M., Sifuentes‐Osornio, J., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.011 · Cited by 24
Clinical features and risk factors for blood stream infections of Candida in neonates
LIU, M., HUANG, S., GUO, L., LI, H., WANG, F., ZHANG, Q., & SONG, G. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2626 · Cited by 23
Epidemiology of candidemia in neonatal intensive care units: a persistent public health problem.
Lovero, G., Giglio, O. D., Montagna, O., Diella, G., Divenuto, F., Lopuzzo, M., Rutigliano, S., Laforgia, N., Caggiano, G., & Montagna, M. T. (2016) · PubMed · doi:10.7416/ai.2016.2107 · Cited by 19 · cited 1×
“Further, studies have identified carbapenem use, total parenteral nutrition, central venous lines use, intubation, congenital malformations, low APGAR score and increased hospital stay as risk factors for neonatal candidemia [64,65].”
BackgroundDesign and use of Candida scores at the intensive care unit
Kratzer, C., Graninger, W., Lassnigg, A. M., & Presterl, E. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01953.x · Cited by 18 · cited 1×
“In a study, this model reaches a negative predictive value of 97%, but sensitivity is only at 34% [89].”
BackgroundNew Approach for Diagnosis of Candidemia Based on Detection of a 65-Kilodalton Antigen
Berzaghi, R., Colombo, A. L., Machado, A. M. D. O., & Camargo, Z. P. D. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00176-09 · Cited by 17 · cited 1×
“The available serological tests include detection of either antibody, antigen or metabolites [78].”
Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
Vuichard, D., Weisser, M., Orasch, C., Frei, R., Heim, D. A., Passweg, J. R., & Widmer, A. F. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0573-5 · Cited by 15 · cited 1×
“Weekly fluconazole prophylaxis instead of daily dosing may be cost-effective for haematological or neutropenic patients to decrease morbidity and mortality due to candidemia [118].”
BackgroundAiming for Zero: Preventing Invasive Candida Infections in Extremely Preterm Infants
Kaufman, D. A. (2011) · NeoReviews · doi:10.1542/neo.12-7-e381 · Cited by 14 · cited 3×
“Similarly, the use of dexamethasone in intubated infants is associated with increased risks of IC and candidemia (10%), respectively [133].”
BackgroundInfluentialErcan, T. E., Sağlam, Ö., Büyükkale, G., Kavuncuoğlu, S., Mete, F., & Çetınkaya, M. (2014) · American Journal of Perinatology · doi:10.1055/s-0034-1371358 · Cited by 13 · cited 1×
“According to gestational age, the incidence of fungal infections is 20%, 10–20%, 5–10% and <5% in <25 weeks, 25–26 weeks, 27–28 weeks and >28 weeks, respectively [68].”
BackgroundNeonatal candidemia: Clinical importance of species identification
Shrivastava, G., Bajpai, T., Bhatambare, G., Chitnis, V., & Deshmukh, A. (2015) · International Medical Journal of Sifa University · doi:10.4103/2148-7731.152115 · Cited by 13
Time to Initiation of Antifungal Therapy for Neonatal Candidiasis
Lê, J., Tran, T. T. L., Bui, I., Wang, M. K., Vo, A., & Adler‐Shohet, F. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02088-12 · Cited by 9 · cited 1×
“5–2 times patients survive) in adults in ICU [110,111,126].”
BackgroundVitale, R. G., & Nucci, M. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0164-8 · Cited by 8 · cited 3×
“Bactec 9240 and Bac/T Alert take around 14–72 h for beeping positive signal based on the culture condition and burden of yeast cells [71,72].”
BackgroundAntimicrobial stewardship program in a developing country: the epidemiological barrier
Lopardo, G. D., Titanti, P., Berdiñas, V., Barcelona, L., & Curcio, D. (2011) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892011001200029 · Cited by 8
Neonatal sepsis and septic shock: Current trends in epidemiology and management
Sherlock, R. L. (2015) · Journal of Pediatric Infectious Diseases · doi:10.3233/jpi-2009-0161 · Cited by 4 · cited 1×
“The attributable mortality rate was recorded at 12–20% [66,67].”
BackgroundFungal Prophylaxis in the Neonatal Intensive Care Unit
Healy, C. M. (2008) · NeoReviews · doi:10.1542/neo.9-12-e562 · Cited by 3
Giuliano, S., Ceccarelli, G., Renzini, V., Magni, G., Baisi, F., Santini, M., & Venditti, M. (2013) · PubMed · doi:10.7416/ai.2013.1906 · Cited by 3 · cited 1×
“demonstrated the use of topical prophylaxis with nystatin and adequate CVC management in neurosurgical ICU to prevent IC [114].”
BackgroundThe vulnerable very low birth weight infant: Late onset bloodstream infections
Gibbs, K., Kleinman, L. C., Jenkins, S. G., Herold, B. C., & Holzman, I. R. (2010) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-2010-0103 · Cited by 1
Research works printed but not linked: 1
- Chakrabarti, A. (2013). Fungal Infections in Asia: The Eastern Frontier of Mycology, Elsevier. [1st ed.].
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
Preterm birth and sustained inflammation: consequences for the neonate
Humberg, A., Fortmann, I., Siller, B., Kopp, M. V., Herting, E., Göpel, W., Härtel, C., & German Neonatal Network, G. C. F. L. R. A. P. I. A. T. B. O. L. (. C. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00803-2 · Cited by 310
Mechanisms of Pathogenic Candida Species to Evade the Host Complement Attack
Singh, D. K., Tóth, R., & Gácser, A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00094 · Cited by 119
“…2013) Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) FH and FHL-1, (Luo et al., 2013a) High-affinity glucose transporter 1(CaHgt1p) FH and C4BP (Lesiak-Markowicz et al., 2011; Kenno et al., 2019) FH and plasminogen remain functional and retain their protease activity (Poltermann et al., 2007).”
BackgroundKim, H. Y., Nguyen, T. A., Kidd, S. E., Chambers, J., Alastruey‐Izquierdo, A., Shin, J.-H., Dao, A., Forastiero, A., Wahyuningsih, R., Chakrabarti, A., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae042 · Cited by 123
Self-citationMathur, P., Hasan, F., Singh, P. K., Malhotra, R., Walia, K., & Chowdhary, A. (2018) · Mycoses · doi:10.1111/myc.12790 · Cited by 86
Metadata
- Authors
- Kaur, H., & Chakrabarti, A.
- Affiliations
- Post Graduate Institute of Medical Education and Research (IN)
- Corresponding author
- Chakrabarti, Arunaloke
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2017-07-19
- Volume
- 3
- Issue
- 3
- Pages
- 41
- ISSN
- 2309-608X (ISSN-L)
- PMC
- PMC5715942
- OpenAlex
- W2738952261
- Cited by
- 93
- References
- 146
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 14 · 2023: 14 · 2022: 8 · 2021: 13 · 2020: 11 · 2019: 9 · 2018: 5 · 2017: 1
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Fungi (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- candidemia, invasive fungal infections, mortality reduction, neonatal candidemia, Candida auris, drug resistance, resource-limited settings, developing countries, antifungal stewardship, infection control, antibiotic misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.